The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 123-129

  Cassell, Sarah E ^a   Bieber, Jeffry D ^a   Rich, Phoebe ^b   Tutuncu, Zuhre N ^a   Lee, Susan J ^a   Kalunian, Kenneth C ^a   Wu, Christopher W ^a   Kavanaugh, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Nail; Nail psoriasis severity index; Outcome measures; Psoriasis; Psoriatic arthritis

Indexed keywords

ADALIMUMAB; ALEFACEPT; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; INTERRATER RELIABILITY; MALE; MEDICAL PHOTOGRAPHY; MODIFIED NAIL PSORIASIS SEVERITY INDEX; NAIL DISEASE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; SCORING SYSTEM; SKIN DISEASE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33846254645     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Schon M, Boeknck WH. Psoriasis. N Engl J Med 2005;352:1899-912.
2. Gladman DD. Psoriatic arthritis. Rheum Dis Clin North Am 1998;24:829-44.
3. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995;22:675-9.
4. Elkayam O, Ophir J, Yaron M, Caspi D. Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 2000;19:301-5.
5. Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: a prospective clinical study. J Cutan Med Surg 2003;7:317-24.
6. Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP. Extended report: nail disease in psoriatic arthritis - clinically important, potentially treatable and often overlooked. Rheumatology Oxford 2004;43:790-4. Epub 2004 Apr 27.
7. Richter MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. J Rheumatol 1999;26:1752-6.
8. de Jong EMGJ, Seegers BAMPA, Gulinck MK, Boezeman JBM, van de Kerkhof PCM. Psoriasis of the nails is associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology 1996;193:300-3.
9. Omura EF. Histopathology of the nail. Dermatol Clin 1985;3:531-41.
10. Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003;49:206-12.
11. Cassell S, Kavanaugh A. Systematic review of therapies for psoriatic nail disease. J Rheumatol 2006;33:1452-6.
12. Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S. Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 2005;52:736-7.
13. Cassetty CT, Alexis AF, Shupack JL, Strober BE. Alefacept in the treatment of psoriatic nail disease: A small case series. J Am Acad Dermatol 2005;52:1101-2.
14. Reich K, Nestle F, Papp K, et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double blind trial. Lancet 2005;366:1367-74.
15. Parrish CA, Sobera JA, Elewski BE. Modifications of the nail psoriasis severity index [letter]. J Am Acad Dermatol 2005;53:745-6.
16. Rich P, Scher R. Modifications of the Nail Psoriasis Severity Index [author's reply]. J Am Acad Dermatol 2005;53:746-7.
17. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: outcomes of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994;33:834-9.
18. Scarpa R, Manguso F, Oriente A, Peluso R, Atteno M, Orient P. Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis? Clin Rheumatol 2004;23:27-30.
19. Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: Are they the same? Arthritis Rheum 2006;54:1328-33.